Resilience19 wrote: @Momen, i think you're right about Marshall being evasive when asked about the possibility of buying SCRN.
This said, for having followed SCRN since its March inception, I wouldn't be hot at the idea of DM buying them. They shold, rather, focus on what they currently have (telehealth, concierge, test kits).
If DM was to get involved in a M&A, I'd prefer them doing so with a well established business that could help them land and expand their AI. One business I have in mind is the likes of D-Box (DBO.V), which could provide DM a new entertainment/training vertical, while complementing its current business - understanding DBO has a very broad customer base and partners, including in the defence, productions etc sectors. At a mc of $24M, I could see DM buy 50% of DBO in a mix of COVID-generated cash and shares, thereby significantly growing DM's rollodex. As an example, DBO's most recent Annual/Q4 released results (https://stockhouse.com/news/press-releases/2021/06/07/d-box-technologies-reports-fourth-quarter-and-fiscal-year-2021-results) highlight for the Fiscal Year ended March 31, 2021;
- Cash and cash equivalents were $9.1 million as of March 31, 2021 compared to $4.1 million as of March 31, 2020.
- Total revenues decreased to $11.1 million from $25.9 million for the same period last year as a result of the adverse impact of the COVID-19 pandemic.
- Net loss decreased to $6.2 million from $6.3 million for the same period last year
- Adjusted EBITDA* decreased to $(3.5) million from $0.6 million for the same period last year.
- Cash flow used in operating activities was $0.3M in FY2021 compared to $3.0M in FY2020 owing to cash management strategies of working capital.
DBO is certainly not a perfect company but between paying $11M for SCRN or $12M for 50% of the likes of DBO, I'd tend to go for the latter.
My two cents
MomenTom wrote: I don't think the last part is true. During last discord Marshall got asked if they would buy ScreenPro and he answered that he cannot discuss that kind of information but that if they acquire it, we will know in a news release along with everyone else.
I would dare say DM cannot perform testing, but they can own a subsidiary who does. (I may very well be wrong, just saying)
PercySweetwater wrote: TSX regulators would not allow DM to administer tests, which is why Screen Pro was set up in the first place. TSX regulators would not allow DM to purchase Screen Pro.